I just noticed that, per the last 10_Q, CTTC's agreement with GEOMC expires in 2017.
Given that apparently CTTC hasn't paid them much if any of the 4 plus million bucks they GEOMC, and given that the likelihood of CTTC being ABLE to pay GEOMC before 2017 is probably nil, I guess it's fair to speculate that GEOMC won't be making anymore calmares after 2017.
But who will? Based on that history, I would expect any potential manufacturers would demand cash on the barrel head before delivering so much as the time of day to CTTC.
Of course, with the planned 1 for 10 reverse split and the name change, maybe CTTC is planning on getting out of the medical device business altogether.
Wouldn't that be SPECIAL!
